Memorial Sloan Kettering Cancer Center Update on the Multimodality Management of Bladder and Kidney Cancer 2024

50 $

Format : 45 videos + 37 pdfs

File size: 6.04 GB

Category: Video Medical

Description
Reviews (0)

Date & Location Thursday, November 21, 2024, 12:00 PM – Saturday, November 23, 2024, 1:00 PM, Zuckerman Research Center, 417 East 68th Street, New York, NY

Specialties

Specialties – Anatomic Pathology, Biostatistics, Clinical Pathology, Cytopathology, Epidemiology, General Surgery, Genetic Counseling, Genitourinary Oncology, Hospitalist, Immunotherapy, Industry, Internal Medicine, Molecular Biology, Molecular Pathology, Nuclear Medicine, Nursing, Oncology and Hematology, Pathology, Patient or Caregiver, Physician Assistant, Radiation Oncology, Surgical Oncology, Surgical Pathology, Urology

Overview

This program is designed to highlight the latest developments in the multidisciplinary management of bladder and kidney cancers. The aim of the course is provide attendees with information that will aid in the delivery of state-of-the-art care to patients with all stages of bladder and kidney cancers. Highlights of this year’s program include:

— Management strategies for localized kidney cancer and non-muscle invasive bladder cancer
— Neoadjuvant and adjuvant systemic therapies for muscle-invasive bladder cancer
— Treatment paradigms for advanced kidney cancer and optimal surgical approaches for high-risk cases
— Advanced imaging modalities for kidney cancer
— The role of intraoperative and SBRT techniques for treating bladder and kidney cancers
— A review of hereditary kidney cancer syndromes

The keynote presentation will detail the new standards in managing advanced urothelial cancer. Updated trial data will be presented, detailing recent changes in the standard of care for advanced urothelial cancer, focusing on combination therapies that include novel antibody-drug conjugates and checkpoint inhibitors. Additionally, the program will include video sessions that highlight surgical techniques for urinary diversion, utilizing both open and robotic methods, as well as radical nephrectomy with thrombectomy.

This course is intended for urologists, urologic-oncologists, medical oncologists, radiation oncologists, pathologists, radiologists, nurses, and other healthcare professionals.

Objectives

At the conclusion of this program, attendees will be able to:

Present a multidisciplinary approach to the management of bladder and kidney cancer including surgical, medical, and radiation therapies
Disseminate knowledge of new approaches to the multidisciplinary management of bladder and kidney cancer
Integrate new therapeutics into the treatment of localized, locally advanced, and metastatic bladder and kidney cancers

+ Topics:

Ablation Strategies for Small Renal Masses.mp4
Ablation Strategies for Small Renal Masses.pdf
Atypical Recurrences Following Minimal Invasive Kidney Surgeries.mp4
Atypical Recurrences Following Minimal Invasive Kidney Surgeries.pdf
Bladder Preservation Options for Muscle Invasive Bladder Cancer- I. Systemic Therapy Alone.mp4
Bladder Preservation Options for Muscle Invasive Bladder Cancer- I. Systemic Therapy Alone.pdf
Bladder Preservation Options for Muscle Invasive Bladder Cancer- II. Partial Cystectomy.mp4
Bladder Preservation Options for Muscle Invasive Bladder Cancer- II. Partial Cystectomy.pdf
Bladder Preservation Options for Muscle Invasive Bladder Cancer- III. Trimodality Therapy.mp4
Bladder Preservation Options for Muscle Invasive Bladder Cancer- III. Trimodality Therapy.pdf
BladderKidney2024_Brochure.pdf
Contemporary Nuclear Medicine Diagnostics in Renal Cell Carcinoma.mp4
Contemporary Nuclear Medicine Diagnostics in Renal Cell Carcinoma.pdf
Contemporary QOL After Radical Cystectomy and Urinary Diversion- MSK Prospective Trial Data.mp4
Contemporary QOL After Radical Cystectomy and Urinary Diversion- MSK Prospective Trial Data.pdf
Contemporary Standards in the Treatment of Refractory Renal Cell Carcinoma.mp4
Contemporary Standards in the Treatment of Refractory Renal Cell Carcinoma.pdf
Current Paradigms in the Management of Newly Diagnosed Metastatic Renal Cell Carcinoma.mp4
Current Paradigms in the Management of Newly Diagnosed Metastatic Renal Cell Carcinoma.pdf
Current Status of BCG Shortage- Management Alternatives and Strategies for NMIBC.mp4
Current Status of BCG Shortage- Management Alternatives and Strategies for NMIBC.pdf
Current Surgical Paradigms in the Management of Small Renal Masses.mp4
Current Surgical Paradigms in the Management of Small Renal Masses.pdf
Emerging Role of Urinary Markers for NMIBC Detection.mp4
Emerging Role of Urinary Markers for NMIBC Detection.pdf
Enhancing Outpatient Support to Improve Outcomes in Bladder Cancer.mp4
Enhancing Outpatient Support to Improve Outcomes in Bladder Cancer.pdf
Evolving Role of Cytoreductive Nephrectomy and Metastasectomy in the Era of Checkpoint Inhibitor Therapy.mp4
Evolving Role of Cytoreductive Nephrectomy and Metastasectomy in the Era of Checkpoint Inhibitor Therapy.pdf
Hereditary GU Syndromes and RCC Panel Discussion Q&A.mp4
Hereditary Syndromes with Predisposition to Bladder and Kidney Cancers.mp4
Hereditary Syndromes with Predisposition to Bladder and Kidney Cancers.pdf
Impact of Variant Histology on Urothelial Cancer Treatment.mp4
Impact of Variant Histology on Urothelial Cancer Treatment.pdf
Later Line Therapies.mp4
Later Line Therapies.pdf
Localized and Metastatic Bladder Cancer Panel Discussion Q&A.mp4
Localized Bladder Cancer (I & II) Panel Discussion Q&A and Case Presentations.mp4
Localized Kidney Cancer (I & II) Panel Discussion Q&A and Case Presentations.mp4
Locally Advanced Kidney Cancer Panel Discussion Q&A and Case Presentations.mp4
Management of Brain and Spinal Cord Metastases Using Contemporary Radiation Strategies.mp4
Management of Brain and Spinal Cord Metastases Using Contemporary Radiation Strategies.pdf
Management of IVC Thrombi in the Era of Immunotherapy.mp4
Management of IVC Thrombi in the Era of Immunotherapy.pdf
Management of Skin Toxicities of Antibody Drug Conjugates and Immune Checkpoint Inhibitors.mp4
Management of Skin Toxicities of Antibody Drug Conjugates and Immune Checkpoint Inhibitors.pdf
Metastatic Kidney Cancer (I) Panel Discussion Q&A and Case Presentations.mp4
Metastatic Kidney Cancer (II) Panel Discussion Q&A and Case Presentations.mp4
Modern ERAS Protocols for Radical Cystectomy.mp4
Modern ERAS Protocols for Radical Cystectomy.pdf
Molecular Imaging for Bladder Cancer- Now and Future.mp4
Molecular Imaging for Bladder Cancer- Now and Future.pdf
New Approaches for High Risk Localized Upper Tract Urothelial Cancer.mp4
New Approaches for High Risk Localized Upper Tract Urothelial Cancer.pdf
New Standards in the Management of Advanced Urothelial Cancer.mp4
New Standards in the Management of Advanced Urothelial Cancer.pdf
Non-Muscle Invasive Bladder Cancer Panel Discussion Q&A and Case Presentations.mp4
Novel Approaches in the Systemic Treatment of Advanced Renal Cell Carcinoma.mp4
Novel Approaches in the Systemic Treatment of Advanced Renal Cell Carcinoma.pdf
Pivotal Data for Adjuvant Immunotherapy in Resected Renal Cell Carcinoma.mp4
Pivotal Data for Adjuvant Immunotherapy in Resected Renal Cell Carcinoma.pdf
Review of Randomized Trial Data for the Role of Pelvic Lymph Node Dissection in Muscle Invasive Bladder Cancer.mp4
Review of Randomized Trial Data for the Role of Pelvic Lymph Node Dissection in Muscle Invasive Bladder Cancer.pdf
Role for Surgery in Advanced Disease.mp4
Role for Surgery in Advanced Disease.pdf
Role for White Light Enhanced Technologies for Bladder Cancer Detection and Treatment.mp4
Role for White Light Enhanced Technologies for Bladder Cancer Detection and Treatment.pdf
SBRT as a Strategy to Treat Renal Masses in the Non-Metastatic Setting.mp4
SBRT as a Strategy to Treat Renal Masses in the Non-Metastatic Setting.pdf
SBRT to non-CNS sites in the Management of Advanced Kidney Cancer.mp4
SBRT to non-CNS sites in the Management of Advanced Kidney Cancer.pdf
Surveillance Strategies for Small Renal Masses.mp4
Surveillance Strategies for Small Renal Masses.pdf
Systemic Treatment for Uncommon Kidney Cancer Variants.mp4
Systemic Treatment for Uncommon Kidney Cancer Variants.pdf
The Role of Adjuvant Therapy for High-Risk Muscle Invasive Bladder Cancer.mp4
The Role of Adjuvant Therapy for High-Risk Muscle Invasive Bladder Cancer.pdf
Update on Treatment Options for BCG Unresponsive NMIBC.mp4
Update on Treatment Options for BCG Unresponsive NMIBC.pdf
Updates in Neoadjuvant Therapy for Muscle Invasive Bladder Cancer.mp4
Updates in Neoadjuvant Therapy for Muscle Invasive Bladder Cancer.pdf
VIDEO SESSION- Tips and Tricks for Continent Urinary Diversion.mp4